AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Breast cancer
Breast cancer
FDA Approves New Option for Advanced or Metastatic Breast Cancer
03/14/2017
The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.
03/14/2017
Breast cancer
Breast cancer
FDA Approves New Option for Advanced or Metastatic Breast Cancer
03/14/2017
The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.
03/14/2017
urinary dysfunction
urinary dysfunction
FDA Approves Nasal Spray For Nocturnal Polyuria
03/06/2017
The FDA has approved Noctiva (desmopressin acetate) nasal spray for the treatment of frequent nighttime urination due to the overproduction of urine.
03/06/2017
urinary dysfunction
urinary dysfunction
FDA Approves Nasal Spray For Nocturnal Polyuria
03/06/2017
The FDA has approved Noctiva (desmopressin acetate) nasal spray for the treatment of frequent nighttime urination due to the overproduction of urine.
03/06/2017
urinary dysfunction
urinary dysfunction
FDA Approves Nasal Spray For Nocturnal Polyuria
03/06/2017
The FDA has approved Noctiva (desmopressin acetate) nasal spray for the treatment of frequent nighttime urination due to the overproduction of urine.
03/06/2017
Allergies
Allergies
FDA: New Treatment for House Dust Mite Allergies
03/02/2017
The US Food and Drug Administration has approved Odactra for the treatment of house dust mite-induced nasal inflammation.
03/02/2017
Allergies
Allergies
FDA: New Treatment for House Dust Mite Allergies
03/02/2017
The US Food and Drug Administration has approved Odactra for the treatment of house dust mite-induced nasal inflammation.
03/02/2017
Allergies
Allergies
FDA: New Treatment for House Dust Mite Allergies
03/02/2017
The US Food and Drug Administration has approved Odactra for the treatment of house dust mite-induced nasal inflammation.
03/02/2017
diarrhea
diarrhea
FDA Approves New Treatment for Carcinoid Syndrome Diarrhea
03/01/2017
The FDA has approved Xermelo to be used in combination with somatostatin analogue therapy for the treatment of carcinoid syndrome diarrhea.
03/01/2017
diarrhea
diarrhea
FDA Approves New Treatment for Carcinoid Syndrome Diarrhea
03/01/2017
The FDA has approved Xermelo to be used in combination with somatostatin analogue therapy for the treatment of carcinoid syndrome diarrhea.
03/01/2017